Updated on 2026/05/25

写真a

 
NISHIHARA SAEKA
 
Organization
Graduate School of Drug Discovery Sciences Department of Drug Discovery Sciences Assistant Professor
School of Science Department of Biological Chemistry
Title
Assistant Professor
Affiliation
Institute of Drug Discovery Sciences

Position

  • Graduate School of Drug Discovery Sciences Department of Drug Discovery Sciences 

    Assistant Professor  2026.04 - Now

  • School of Science Department of Biological Chemistry 

    Assistant Professor  2026.04 - Now

Degree

  • 博士(薬学) ( Doshisha Women's College of Liberal Arts )

Research Areas

  • Life Science / Pharmaceutical hygiene and biochemistry

Research Interests

  • 自然免疫

  • 抗菌ペプチド

Professional Memberships

  • 日本薬学会

  • 日本生化学会

  • 日本エンドトキシン・自然免疫研究会

Awards

  • 日本エンドトキシン・自然免疫研究会 優秀賞

    2024.11  

  • 第95回日本生化学会大会 若手優秀発表賞

    2022.11  

  • 日本薬学会 第142年会 ポスター発表の部 優秀発表賞

    2022.03  

  • 日本薬学会 第137年会 ポスター発表の部 優秀発表賞

    2017.03  

Papers

  • Lipopolysaccharide uptake is augmented in lipopolysaccharide-tolerant mouse macrophage-like cells via increased CD14 expression. Reviewed OA

    Saeka Nishihara, Takayuki Manabe, Mika Jouta, and Kiyoshi Kawasaki

    FEBS open bio   2026.04

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Lipopolysaccharide (LPS) tolerance can be recognized as a modulation of innate immune responses rather than merely a hyporesponsiveness to LPS, with CD14 being crucial for both LPS uptake and LPS signaling. In this study, we observed that LPS-tolerant mouse macrophage-like cells, in which LPS-induced TNF-α and IFN-β production was suppressed, exhibited a dramatic increase in surface CD14 expression. Also, we found that LPS uptake was enhanced in LPS-tolerant mouse macrophage-like cells, but not when treated with an anti-CD14 antibody. While previous studies have reported increased CD14 expression and enhanced LPS uptake in LPS-tolerant cells, our findings reveal that overexpressed CD14 in LPS-tolerant mouse macrophage-like cells is responsible for the enhanced LPS uptake in these cells.

    DOI: 10.1002/2211-5463.70261

    PubMed

  • High amphipathicity of α-helical peptides enhances unmethylated CpG DNA-induced activation of mouse macrophage-like RAW264.7 cells Reviewed OA

    Saeka Nishihara, Nao Nakamura, and Kiyoshi Kawasaki

    Scientific Reports   14 ( 1 )   2024.07( eISSN:2045-2322

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)  

    Abstract

    The α-helical antimicrobial peptide Kn2-7 enhances the activation of mouse macrophage-like RAW264.7 induced by DNA containing unmethylated cytosine-guanine motifs (CpG DNA). This enhancement is related to increased cellular uptake of DNA by Kn2-7, but the relevant properties of Kn2-7 are unknown. Physicochemical property analysis revealed that Kn2-7 has high amphipathicity. In contrast, the α-helical antimicrobial peptide L5, which increases the cellular uptake of CpG DNA but does not enhance CpG DNA-induced activation, has low amphipathicity. Kn2-7 derivatives with decreased amphipathicity but the same amino acid composition as Kn2-7 did not enhance CpG DNA-induced activation. On the other hand, L5 derivatives with high amphipathicity but the same amino acid composition as L5 enhanced CpG DNA-induced activation. Cellular uptake of DNA was not increased by the L5 derivatives, indicating that high amphipathicity does not affect DNA uptake. Furthermore, α-helical peptides with reversed sequences relative to the Kn2-7 and L5 derivatives with high amphipathicity were synthesized. The reversed-sequence peptides, which had the same amphipathicity but different amino acid sequences from their counterparts, enhanced CpG DNA-induced activation. Taken together, these observations indicate that the high amphipathicity of α-helical peptides enhances the CpG DNA-induced activation of RAW264.7.

    DOI: 10.1038/s41598-024-67166-8

    Other URL: https://www.nature.com/articles/s41598-024-67166-8

  • A tailored tetravalent peptide displays dual functions to inhibit amyloid β production and aggregation Reviewed

    Waka Sato, Miho Watanabe-Takahashi, Takuya Murata, Naoko Utsunomiya-Tate, Jun Motoyama, Masataka Anzai, Seiko Ishihara, Nanako Nishioka, Hina Uchiyama, Juri Togashi, Saeka Nishihara, Kiyoshi Kawasaki, Takashi Saito, Takaomi C. Saido, Satoru Funamoto, and Kiyotaka Nishikawa

    Communications Biology   6 ( 1 )   2023.04( eISSN:2399-3642

     More details

    Publishing type:Research paper (scientific journal)  

    Abstract

    Inhibition of amyloid-β peptide (Aβ) accumulation in the brain is a promising approach for treatment of Alzheimer’s disease (AD). Aβ is produced by β-secretase and γ-secretase in endosomes via sequential proteolysis of amyloid precursor protein (APP). Aβ and APP have a common feature to readily cluster to form multimers. Here, using multivalent peptide library screens, we identified a tetravalent peptide, LME-tet, which binds APP and Aβ via multivalent interactions. In cells, LME-tet-bound APP in the plasma membrane is transported to endosomes, blocking Aβ production through specific inhibition of β-cleavage, but not γ-cleavage. LME-tet further suppresses Aβ aggregation by blocking formation of the β-sheet conformation. Inhibitory effects are not observed with a monomeric peptide, emphasizing the significance of multivalent interactions for mediating these activities. Critically, LME-tet efficiently reduces Aβ levels in the brain of AD model mice, suggesting it may hold promise for treatment of AD.

    DOI: 10.1038/s42003-023-04771-9

    Other URL: https://www.nature.com/articles/s42003-023-04771-9

  • Relationship Between Affinity of Kn2-7 to CpG DNA and the Ability of Kn2-7 to Enhance Cellular Uptake of CpG DNA by RAW264.7 Cells Reviewed OA

    Saeka Nishihara, Mayu Wakita, and Kiyoshi Kawasaki

    BPB Reports   4 ( 2 )   55 - 58   2021.03( eISSN:2434-432X

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)  

    DOI: 10.1248/bpbreports.4.2_55

  • Enhanced cellular uptake of CpG DNA by α-helical antimicrobial peptide Kn2-7: Effects on macrophage responsiveness to CpG DNA Reviewed

    Saeka Nishihara, and Kiyoshi Kawasaki

    Biochemical and Biophysical Research Communications   530 ( 1 )   100 - 106   2020.09( ISSN:0006-291X

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bbrc.2020.07.013

MISC

Grant-in-Aid for Scientific Research

  • 感染症治療の新基盤となる、両親媒性抗菌ペプチドのCpG-DNA刺激応答増強機構の解明

    Grant-in-Aid for Early-Career Scientists  2027

  • 感染症治療の新基盤となる、両親媒性抗菌ペプチドのCpG-DNA刺激応答増強機構の解明

    Grant-in-Aid for Early-Career Scientists  2026

  • 感染症治療の新基盤となる、両親媒性抗菌ペプチドのCpG-DNA刺激応答増強機構の解明

    Grant-in-Aid for Early-Career Scientists  2025.04

Incentive donations / subsidies

  • 非メチル化CpG DNAの免疫刺激活性を増強する抗菌ペプチド

    日本私立学校振興・共済事業団   若手研究者奨励金  2024.05

Charge of on-campus class subject

  • 研究企画ゼミナール2

    2026   Intensive lecture   Graduate school

  • 創薬科学特別研究5

    2026   Intensive lecture   Graduate school

  • 創薬科学特別演習5

    2026   Intensive lecture   Graduate school

  • 機能生化学特論

    2026   Weekly class   Graduate school

  • 研究企画ゼミナール1

    2026   Intensive lecture   Graduate school

  • 創薬科学特別研究1

    2026   Intensive lecture   Graduate school

  • 創薬科学特別演習1

    2026   Intensive lecture   Graduate school

  • 生物化学卒業研究A

    2026   Intensive lecture   Undergraduate

  • 生物化学卒業演習A

    2026   Intensive lecture   Undergraduate

▼display all